Douglas Lane & Associates LLC Trims Stake in CVS Health Corporation $CVS

Douglas Lane & Associates LLC lowered its holdings in CVS Health Corporation (NYSE:CVS) by 4.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 563,420 shares of the pharmacy operator’s stock after selling 28,965 shares during the period. Douglas Lane & Associates LLC’s holdings in CVS Health were worth $42,476,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Red Door Wealth Management LLC bought a new stake in CVS Health during the third quarter valued at approximately $272,000. Trust Point Inc. purchased a new stake in shares of CVS Health during the 3rd quarter valued at $272,000. Corsicana & Co. bought a new stake in shares of CVS Health during the 3rd quarter worth $357,000. Fiduciary Financial Group LLC purchased a new position in CVS Health in the third quarter worth $429,000. Finally, AdvisorNet Financial Inc grew its position in CVS Health by 541.5% in the third quarter. AdvisorNet Financial Inc now owns 21,478 shares of the pharmacy operator’s stock worth $1,619,000 after acquiring an additional 18,130 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS stock opened at $77.70 on Friday. The company has a market capitalization of $98.63 billion, a P/E ratio of 204.47, a PEG ratio of 0.77 and a beta of 0.48. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The stock has a 50 day moving average price of $79.09 and a two-hundred day moving average price of $72.43.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on CVS shares. Barclays lifted their price target on CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Zacks Research downgraded CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. The Goldman Sachs Group increased their price target on shares of CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research note on Wednesday. Finally, TD Cowen upped their price objective on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, December 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $94.67.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.